Literature DB >> 10395562

Mechanism and regulation of transcriptional elongation by RNA polymerase II.

D Reines1, R C Conaway, J W Conaway.   

Abstract

Over the past few years, biochemical and genetic studies have shed considerable light on the structure and function of the RNA polymerase II (pol II) elongation complex and the transcription factors that control it. Novel elongation factors have been identified and their mechanisms of action characterized in increasing detail; new insights into the biological roles of elongation factors have been gained from genetic studies of the regulation of mRNA synthesis in yeast; and intriguing links between the pol II elongation machinery and the pathways of DNA repair and recombination have emerged.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395562      PMCID: PMC3371606          DOI: 10.1016/S0955-0674(99)80047-7

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  54 in total

1.  Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase.

Authors:  N F Marshall; J Peng; Z Xie; D H Price
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

2.  Evidence for a mediator cycle at the initiation of transcription.

Authors:  J Q Svejstrup; Y Li; J Fellows; A Gnatt; S Bjorklund; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.

Authors:  C A Parada; R G Roeder
Journal:  Nature       Date:  1996-11-28       Impact factor: 49.962

4.  Mechanism and regulation of transcriptional elongation and termination by RNA polymerase II.

Authors:  A Shilatifard; J W Conaway; R C Conaway
Journal:  Curr Opin Genet Dev       Date:  1997-04       Impact factor: 5.578

5.  Recombination between DNA repeats in yeast hpr1delta cells is linked to transcription elongation.

Authors:  F Prado; J I Piruat; A Aguilera
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  In vitro characterization of mutant yeast RNA polymerase II with reduced binding for elongation factor TFIIS.

Authors:  J Wu; D E Awrey; A M Edwards; J Archambault; J D Friesen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

7.  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function.

Authors:  X Yang; C H Herrmann; A P Rice
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1.

Authors:  R F Chun; K T Jeang
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

9.  Activator-dependent regulation of transcriptional pausing on nucleosomal templates.

Authors:  S A Brown; A N Imbalzano; R E Kingston
Journal:  Genes Dev       Date:  1996-06-15       Impact factor: 11.361

10.  Mutations in the RNA polymerase II transcription machinery suppress the hyperrecombination mutant hpr1 delta of Saccharomyces cerevisiae.

Authors:  H Y Fan; K K Cheng; H L Klein
Journal:  Genetics       Date:  1996-03       Impact factor: 4.562

View more
  30 in total

Review 1.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.

Authors:  E Querido; P Blanchette; Q Yan; T Kamura; M Morrison; D Boivin; W G Kaelin; R C Conaway; J W Conaway; P E Branton
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

3.  Strong natural pausing by RNA polymerase II within 10 bases of transcription start may result in repeated slippage and reextension of the nascent RNA.

Authors:  Mahadeb Pal; Donal S Luse
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  Promoter clearance by RNA polymerase II is an extended, multistep process strongly affected by sequence.

Authors:  M Pal; D McKean; D S Luse
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1.

Authors:  A C Goldstrohm; T R Albrecht; C Suñé; M T Bedford; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.

Authors:  Takumi Kamura; Katsumi Maenaka; Shuhei Kotoshiba; Masaki Matsumoto; Daisuke Kohda; Ronald C Conaway; Joan Weliky Conaway; Keiichi I Nakayama
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

9.  Genetic interactions of DST1 in Saccharomyces cerevisiae suggest a role of TFIIS in the initiation-elongation transition.

Authors:  Francisco Malagon; Amy H Tong; Brenda K Shafer; Jeffrey N Strathern
Journal:  Genetics       Date:  2004-03       Impact factor: 4.562

10.  The Ras/PKA signaling pathway may control RNA polymerase II elongation via the Spt4p/Spt5p complex in Saccharomyces cerevisiae.

Authors:  Susie C Howard; Arelis Hester; Paul K Herman
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.